ロード中...
In Vitro and In Vivo Activities of the Riminophenazine TBI-166 against Mycobacterium tuberculosis
The riminophenazine agent clofazimine (CFZ) is repurposed as an important component of the new short-course multidrug-resistant tuberculosis regimen and significantly shortens first-line regimen for drug-susceptible tuberculosis in mice. However, CFZ use is hampered by its unwelcome skin discolorati...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6496038/ https://ncbi.nlm.nih.gov/pubmed/30782992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02155-18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|